Folate Interactions

Phenytoin lowers serum and red-cell folate through enzyme induction and impaired absorption of polyglutamate folates, but high-dose folate supplementation in turn accelerates phenytoin metabolism and can drop drug levels enough to cause seizure breakthrough.

Chronic alcohol use causes folate deficiency through multiple mechanisms: it inhibits the reduced folate carrier in the intestine (blocking absorption), reduces hepatic uptake and storage, and increases urinary folate excretion. Folate depletion accelerates alcohol-induced liver injury and disrupts one-carbon metabolism and DNA methylation.

Lamotrigine inhibits dihydrofolate reductase, the enzyme that converts dihydrofolate to active tetrahydrofolate, and high-dose folic acid supplementation has been shown to blunt lamotrigine's antidepressant effect in bipolar depression (CEQUEL trial), particularly in COMT Met allele carriers. The interaction is pharmacodynamic rather than pharmacokinetic, so lamotrigine blood levels remain unchanged.

Methotrexate works by inhibiting dihydrofolate reductase, depleting active folate and causing GI, mucosal, and hepatic side effects. Folic acid supplementation reduces those side effects by 26-77% without compromising efficacy, but must be timed correctly to avoid blunting the drug's action.

Oral contraceptive use is associated with lower plasma and red blood cell folate levels, likely through increased turnover and urinary excretion. Because pregnancies can occur shortly after stopping the pill, low folate stores increase the risk of neural tube defects in any unplanned conception.

Green tea and EGCG inhibit the proton-coupled folate transporter (PCFT) in the small intestine and inhibit dihydrofolate reductase, the enzyme that converts folic acid into its active form. In humans, concomitant green tea reduced folic acid Cmax by about 58% and AUC by about 44%.

Vitamin B12 and folate are interdependent coenzymes in the methionine cycle: methylfolate donates a methyl group to homocysteine while B12 (methylcobalamin) is the required cofactor for methionine synthase, the enzyme catalyzing the reaction. Adequate intake of both is needed to lower homocysteine, support DNA synthesis, and prevent the neurologic damage that high-dose folate alone can mask.

Vitamin B6 and folate work in tandem within one-carbon metabolism: folate (as 5-MTHF) donates a methyl group to remethylate homocysteine, while B6 (as PLP) is the cofactor for serine hydroxymethyltransferase and cystathionine beta-synthase, supporting both the folate cycle and the transsulfuration route that disposes of excess homocysteine.